ArticleFrontiers in immunology2023

Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma.

Sare Hajiabadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.